Distinguished Doctors Converged at Royal Cliff and PEACH for the 39th Annual Meeting of the Royal College of Orthopedic Surgeons of Thailand

Food and Healthcare Press Releases Tuesday November 28, 2017 10:25
Bangkok--28 Nov--Royal Cliff Hotels Group

The award-winning Royal Cliff Hotels Group and Pattaya Exhibition And Convention Hall (PEACH) was once again the chosen venue for the 39th Annual Meeting of Royal College of Orthopedic Surgeons of Thailand (RCOST).

RCOST spent 4 days at the award-winning resort where delegates experienced an exchange of current scientific and clinical information for regional and global orthopaedic communities. The annual RCOST meetings have always received tremendous interest in terms of participation and quality of contributions among ASEAN and Asian orthopaedic surgeons. This year's successful meeting ended with an unforgettable Thank you dinner held at Royal Cliff's popular Chinese restaurant, Huang Chao – Royal Cantonese Cuisine.

Situated on a 64 acre private parkland estate overlooking the stunning Gulf of Thailand, the Royal Cliff Hotels Group has been honored with multiple awards and recognition from organizations of national and international repute. It is home to four award winning 5-star hotels offering a sensory experience defined profoundly by its style, culture and elegance - all presented with the distinctive spirit of the State of Exclusivity and Fascination.

PEACH is a world-renowned award-winning convention facility under the flagship of the Royal Cliff Hotels Group. Offering an ideal location, modern facility and professional service, it is the perfect venue to hold any kind of event and can accommodate up to 10,062 people theatre-style. Want to hold your next event at PEACH? Request for a proposal by contacting our Sales Managers at (+66) 38 250 421 Ext: 2845 or emailing: mice@royalcliff.com.

For more information on the Royal Cliff Hotels Group and Pattaya Exhibition And Convention Hall (PEACH), please visit www.royalcliff.com and www.peachthailand.com

Latest Press Release

Merck Signs Distribution Agreement with Avanti(R) Polar Lipids

Merck , a leading science and technology company, today announced that it has entered into an agreement with Avanti(R) Polar Lipids to be the exclusive multinational distributor of the USA-based company's research lipids portfolio outside of the United...

Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for People With Type 2 Diabetes in Real-World Setting

Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes after six months.[1] The study looked at people with type 2...

Tresiba(R) Reduces Hypoglycaemia Regardless of Blood Sugar Level

People with either type 1 or type 2 diabetes treated with Tresiba(R) had fewer episodes of low blood sugar (hypoglycaemia) compared with people on insulin glargine U100 regardless of whether they had achieved blood sugar targets.[1] These new post-hoc...

Ryzodeg(R) Significantly Reduces the Risk of Low Blood Sugar in People With Type 2 Diabetes who Fast During Ramadan

In people with type 2 diabetes who fast during Ramadan, Ryzodeg(R) (insulin degludec/insulin aspart) reduced the overall rate of low blood sugar (hypoglycaemia) including severe episodes by 62% and the rate of nocturnal hypoglycaemia by 74% versus...

Interim Results of First-Ever Global Survey Show People with Type 2 Diabetes Underestimate their Cardiovascular Risk

- Globally, cardiovascular disease (CVD) is the most common cause of death in people with type 2 diabetes[1] - 1 in 3 respondents considered themselves to be at low risk of CVD[2] - 1 in 6 respondents had never discussed type 2 diabetes and...

Related Topics